Clinical relevance before curiosity
ElixirFeed considers whether a finding may change awareness, practice, future trials, or public understanding. Interesting but weakly actionable findings should not dominate the feed.
Clinical research feed
ElixirFeed helps clinicians and serious health readers track selected biomedical papers with evidence-aware summaries and caveats.

clinical research feed
A clinical research feed should not be a dump of every matching paper. ElixirFeed highlights studies that appear more likely to be clinically or practically meaningful, then explains them in a compact format.
Favors strong designs and meaningful endpoints
Calls out uncertainty instead of flattening papers into hype
Supports broad biomedical categories beyond one specialty
Workflow
ElixirFeed keeps the ranking workflow visible because the differentiator is the filter, not generic article rewriting.
ElixirFeed starts with the biomedical firehose rather than one narrow keyword query.
Records without usable abstracts and obvious low-impact matches are removed before enrichment.
Human evidence, clinical relevance, public usefulness, novelty, journal context, and prominence signals shape the score.
The highest-ranking studies become readable briefs with takeaways, caveats, categories, and source links.
ElixirFeed considers whether a finding may change awareness, practice, future trials, or public understanding. Interesting but weakly actionable findings should not dominate the feed.
Selected papers are presented with summaries, known unknowns, and study-type context so readers can separate strong signals from early-stage claims.
The goal is quick triage. Readers can scan titles, study types, journals, summaries, and tags before opening the full paper or PubMed source.
Clinicians keeping up with major findings
Residents and students learning outside assigned reading
Health professionals tracking research without newsletter sprawl
ElixirFeed is a research discovery product, not medical advice or a replacement for source-paper review.
No. Clinicians are one audience, but the feed is also useful for founders, writers, researchers, and health-focused readers.
Yes, when they score highly enough, but human evidence and clinically meaningful outcomes are weighted heavily.
Signed-in users can use account features such as preferences, bookmarks, votes, comments, and subscription-only translations depending on plan.
Start with the public preview, then create a free account when you want the regular recent feed.